Literature DB >> 22628334

Thyroid volume influences serum calcitonin levels in a thyroid-healthy population: results of a 3-assay, 519 subjects study.

Luca Giovanella1, Mauro Imperiali, Anna Ferrari, Alessia Palumbo, Lorella Lippa, Andrea Peretti, Maria Stella Graziani, Roberto Castello, Frederik A Verburg.   

Abstract

BACKGROUND: We aimed to assess determinants for serum calcitonin (CT) levels and to define reference ranges for different CT immunoassays integrating thyroid ultrasonography (TUS) and conventional clinical and biochemical criteria to select the reference population.
METHODS: Five hundred and nineteen thyroid-healthy subjects were included in this prospective cross-sectional population study. Thyroid volume was measured by TUS, while serum CT levels were measured by three different immunoassays.
RESULTS: Significant interassay differences were found and the agreement between assays was poor. CT levels were higher in males than in females in all immunoassays. Using the first two assays, both gender and thyroid volume were independent determinants for CT levels. While using the third assay, one thyroid volume was the only determinant for CT levels.
CONCLUSIONS: Thyroid volume is a relevant determinant for CT levels. In the clinical practice, the difference of the thyroid sizes in males and females warrants gender-specific reference ranges.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22628334     DOI: 10.1515/cclm-2011-0920

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  6 in total

1.  Thyroid volume and serum calcitonin changes during pregnancy.

Authors:  G Vannucchi; D Covelli; B Vigo; M Perrino; L Mondina; L Fugazzola
Journal:  J Endocrinol Invest       Date:  2017-02-22       Impact factor: 4.256

2.  Calcitonin Levels in Thyroid Disease Are Not Affected by Autoimmune Thyroiditis or Differentiated Thyroid Carcinoma.

Authors:  Fabio Maino; Cristina Dalmiglio; Nicoletta Benenati; Michele Campanile; Tania Pilli; Raffaella Forleo; Lucia Brilli; Cristina Ciuoli; Silvia Cantara; Marco Capezzone; Alessandra Cartocci; Furio Pacini; Maria Grazia Castagna
Journal:  Eur Thyroid J       Date:  2020-10-12

3.  Measurement of calcitonin and calcitonin gene-related peptide mRNA refines the management of patients with medullary thyroid cancer and may replace calcitonin-stimulation tests.

Authors:  Cléber P Camacho; Susan C Lindsey; Maria Clara C Melo; Ji H Yang; Fausto Germano-Neto; Flávia de O F Valente; Thiago R N Lima; Rosa Paula M Biscolla; José G H Vieira; Janete M Cerutti; Magnus R Dias-da-Silva; Rui M B Maciel
Journal:  Thyroid       Date:  2013-03       Impact factor: 6.568

4.  Procalcitonin as Marker of Recurrent Medullary Thyroid Carcinoma: A Systematic Review and Meta-Analysis.

Authors:  Pierpaolo Trimboli; Luca Giovanella
Journal:  Endocrinol Metab (Seoul)       Date:  2018-06

5.  The dilemma of routine testing for calcitonin thyroid nodule's patients to detect or exclude medullary carcinoma: one single negative test should be valuable as rule-out strategy to avoid further calcitonin measurements over time.

Authors:  Pierpaolo Trimboli; Chiara Camponovo; Lorenzo Ruinelli
Journal:  Endocrine       Date:  2022-04-07       Impact factor: 3.925

6.  Procalcitonin measurement to screen medullary thyroid carcinoma: A prospective evaluation in a series of 2705 patients with thyroid nodules.

Authors:  Luca Giovanella; Mauro Imperiali; Arnoldo Piccardo; Monica Taborelli; Frederik Anton Verburg; Federica Daurizio; Pierpaolo Trimboli
Journal:  Eur J Clin Invest       Date:  2018-04-20       Impact factor: 4.686

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.